Robust Neutralizing Antibodies to SARS-CoV-2 Develop and Persist in Subjects with Diabetes and COVID-19 Pneumonia

CONTEXT: Demonstrating the ability to mount a neutralizing antibody response to SARS-CoV-2 in the presence of diabetes is crucial to understand COVID-19 pathogenesis, reinfection potential, and vaccine development. OBJECTIVE: The aim of this study was to characterize the kinetics and durability of n...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Clin Endocrinol Metab
Autores principales: Dispinseri, Stefania, Lampasona, Vito, Secchi, Massimiliano, Cara, Andrea, Bazzigaluppi, Elena, Negri, Donatella, Brigatti, Cristina, Pirillo, Maria Franca, Marzinotto, Ilaria, Borghi, Martina, Rovere-Querini, Patrizia, Tresoldi, Cristina, Ciceri, Fabio, Scavini, Marina, Scarlatti, Gabriella, Piemonti, Lorenzo
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2021
Materias:
Clinical Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7928901/
https://ncbi.nlm.nih.gov/pubmed/33513242
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/clinem/dgab055
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares